Vés al contingut

A PHASE IIIb MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OCRELIZUMAB IN ADULTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

Obert
  • Codi protocol: WA40404
  • Codi EudraCT: 2018-001511-73
  • Grup de recerca: Neuroimmunologia Clínica
  • Servei: Neuroimmunologia
  • Investigador/a principal:  Montalban Gairín, Xavier
  • Fase: Fase III
  • Estat reclutament: Reclutant voluntaris